The North American healthcare CDMO market is projected to grow at a significant CAGR during the forecast period. The market is mainly driven due to significant growth in pharmaceutical contract manufacturing in the US and Canada. Outsourcing the manufacturing services in the pharmaceutical industry enables the companies to divert the workforce to other processing tasks, which as a result makes monetary savings and reduces the time for R&D activities. The drug development companies can save up to 30-35% of the drug development cost via contract manufacturing procedure. Therefore, to remain competitive in the market, contract manufacturing is considered crucial support for pharmaceutical companies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-healthcare-cdmo-market
In the region, several pharmaceutical companies are focused on finding ways to minimize the cost of drugs, which in turn forced them to outsource drug manufacturing services. In January 2019, Cambrex Corp. acquired Avista Pharma Solutions to strengthen the position of Cambrex as a prominent fully integrated small molecule contract development and manufacturing organization (CDMO). Avista Pharma Solutions was a contract development, manufacturing, and testing organization. Avista’s four sites in Durham, NC, Longmont, CO, Agawam, MA, and Edinburgh, Scotland, UK will be integrated into the global network of Cambrex. This will expand the company’s geographical presence and strengthen its manufacturing capabilities.
Key Questions Addressed by the Report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
North American healthcare CDMO Market – Segmentation
By Services
- Contract Development
o Clinical
o Preclinical
o Laboratory Services
- Contract Manufacturing
o Active Pharmaceutical Ingredients( API)
o Finish Dosage Formulations
o Medical Devices
A full report of North American Healthcare CDMO Market is available at: https://www.omrglobal.com/industry-reports/north-american-healthcare-cdmo-market
North American Healthcare CDMO Market– Segment by Region
North America
- United States
- Canada
Company Profiles
- AbbVie Inc.
- Baxter International, Inc.
- Catalent Inc.
- Covance Inc.
- Cambrex Corp.
- Hisun Pharmaceuticals Inc.
- Jabil Inc.
- Pfizer Inc.
- Stason Pharmaceuticals, Inc.
- Thermo Fisher Scientific Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research